EMEA-003378-PIP01-23
Submitted by Anonymous (not verified) on 4 October 2024 - 12:35
EMEA-003378-PIP01-23
EMEA-003430-PIP01-23
Submitted by Anonymous (not verified) on 4 October 2024 - 12:35
EMEA-003430-PIP01-23
EMEA-002990-PIP02-23
Submitted by Anonymous (not verified) on 4 October 2024 - 11:52
EMEA-002990-PIP02-23
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024
Submitted by Anonymous (not verified) on 4 October 2024 - 11:30
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024
EMA and European Organisation for Research and Treatment of Cancer (EORTC) workshop: How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?, Online, European Medicines Agency, Amsterdam, the Ne
Submitted by Anonymous (not verified) on 4 October 2024 - 11:10
EMA and European Organisation for Research and Treatment of Cancer (EORTC) workshop: How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 February 2024, 13:00 (CET) to 29 February 2024, 19:00 (CET)
EMEA-003343-PIP01-22
Submitted by Anonymous (not verified) on 4 October 2024 - 10:35
EMEA-003343-PIP01-22
EMEA-003344-PIP01-22
Submitted by Anonymous (not verified) on 4 October 2024 - 10:35
EMEA-003344-PIP01-22
PDCO minutes of the 23-26 July 2024 meeting
Submitted by Anonymous (not verified) on 4 October 2024 - 9:32
PDCO minutes of the 23-26 July 2024 meeting
PSUSA/00000677/202401
Submitted by Anonymous (not verified) on 3 October 2024 - 15:44
PSUSA/00000677/202401
PSUSA/00010289/202402
Submitted by Anonymous (not verified) on 3 October 2024 - 15:33
PSUSA/00010289/202402